A. Ramakrishnan, P. Pornsuriyasak, and A. V. Demchenko
658
(dd, 1H, J3,4 ¼ 9.4 Hz, H-3), 5.08 (dd, 1H, J4,5 ¼ 9.4 Hz, H-4), 5.07 (dd, 1H,
J2,3 ¼ 9.5 Hz, H-2), 4.44–4.62 (m, 2H, CH2O), 4.28 (dd, 1H, J5,6a ¼ 4.9 Hz,
J6a,6b ¼ 12.5 Hz, H-6a), 4.11 (dd, 1H, J5,6b ¼ 1.8 Hz, H-6b), 3.77–3.99 (m, 3H,
H-5, CH2 N), 2.03, 2.05, 2.06, 2.09 (4s, 12H, 4 ꢀ COCH3) ppm; 13C NMR: d,
189.44, 170.71, 170.54, 169.90, 169.78, 84.17, 74.61, 72.74, 68.78, 68.18,
67.70, 61.91, 43.06, 20.93, 20.86 (ꢀ2), 20.77 ppm.
5,6-Dihydro-4H-1,3-oxazin-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-b-D-gluco-
pyranoside (5a) could not be obtained by either Method A or B. 2,3,4,6-
Tetra-O-acetyl-1-N-(5,6-dihydro-4H-2-thione-1,3-oxazin-3-yl)-b-D-gluco-
pyranosylamine (18c) was isolated as a colorless film in the attempt of the
synthesis of 5a from 15 (27%, Method B). Analytical data for 18c: Rf ¼ 0.50
(acetone/toluene, 1/3, v/v); [a]2D6 þ.25.78 (c ¼ 1.25, CHCl3); UV: lmax ¼ 300 nm;
1H NMR: d, 6.77 (d, 1H, J1,2 ¼ 9.4Hz, H-1), 5.43 (dd, 1H, J3,4 ¼ 9.6 Hz, H-3),
5.14 (dd, 1H, J2,3 ¼ 9.5 Hz, H-2), 5.05 (dd, 1H, J4,5 ¼ 9.6 Hz, H-4), 4.20–4.37
(m, 3H, H-6a, CH2O), 4.12 (dd, 1H, J5,6b ¼ 1.9 Hz, J6a,6b ¼ 12.5 Hz, H-6b), 3.89–
3.94 (m, 1H, H-5), 3.51 (dd, 2H, CH2N), 2.13–2.16 (m, 2H, CCH2C), 2.02, 2.05,
2.07, 2.09 (4s, 12H, 4 ꢀ COCH3) ppm; 13C NMR: d, 188.57, 170.74, 170.65,
169.90, 169.84, 87.34, 74.55, 72.96, 68.47, 68.25, 68.15, 61.95, 40.46, 21.15,
20.97 (ꢀ2), 20.78 (ꢀ2) ppm; HR-FAB MS [M þ Na]þ calcd for C18H25NNaO10S
470.1097, found 470.1090.
Benzothiazol-2-yl
2,3,4,6-tetra-O-acetyl-1-thio-b-D-glucopyranoside
(6a) was prepared as white crystals from 14 (Method A) or 15 (Method B) in
85% or 99% yield, respectively. Analytical data for 6a: Rf ¼ 0.38 (ethyl
acetate – toluene, 3/7, v/v); m.p. þ121–1248C (CH2Cl2/ether/hexane); [a]D25
1
þ34.78 (c ¼ 1.04, CHCl3); UV: lmax ¼ 276 nm; H NMR: d, 7.40–8.00 (m, 4H,
aromatic), 5.59 (d, 1H, J1,2 ¼ 10.2 Hz, H-1), 5.33 (dd, 1H, J3,4 ¼ 9.2 Hz, H-3),
5.25 (dd, 1H, J2,3 ¼ 9.2 Hz, H-2), 5.19 (dd, 1H, J4,5 ¼ 10.0 Hz, H-4), 4.32 (dd,
1H, J5,6a ¼ 4.9 Hz, J6a,6b ¼ 12.5 Hz, H-6a), 4.19 (dd, 1H, J5,6b ¼ 1.9 Hz, H-6b),
3.94 (m, 1H, H-5), 2.05, 2.05, 2.05, 2.03 (4s, 12H, 4 ꢀ COCH3) ppm; 13C
NMR: d 170.98, 170.47, 169.78, 162.28, 153.11, 136.21, 126.79 (ꢀ2), 125.45,
122.76 (ꢀ2), 121.43 (ꢀ2), 84.41, 74.17, 70.10, 68.50, 62.26, 21.09, 20.97 (ꢀ2)
ppm; HR-FAB MS [M þ Na]þ calcd. for C21H23NNaO9S2 520.0712, found
520.0717.
5,6-Dihydro-4H-1,3-thiazin-2-yl 2,3,4,6-tetra-O-acetyl-1-thio-b-D-gluco-
pyranoside (7a) was prepared as white crystals from 14 (Method A) or 15
(Method B) in 84% or 22% yield, respectively. Analytical data for 7a:
Rf ¼ 0.53 (ethyl acetate-toluene, 3/7, v/v); m.p. þ102–1048C (CH2Cl2/ether/
1
hexane); [a]2D4 þ9.28 (c ¼ 1.03, CHCl3); UV: lmax ¼ 274 nm; H NMR: d, 5.55
(d, 1H, J1,2 ¼ 10.5 Hz, H-1), 5.27 (dd, 1H, J3,4 ¼ 9.2 Hz, H-3), 5.08–5.15
(m, 2H, J2,3 ¼ 9.2 Hz, H-2, 4), 4.27 (dd, 1H, J5,6a ¼ 4.3 Hz, J6a,6b ¼ 12.4 Hz,